Evaluation of the influence of ozonotherapy on the clinical parameters and MMP levels in patients with chronic and aggressive periodontitis

Advances in Medical Sciences

Volumn 55, Issue 2, 2010, Pages 297-307

  Skurska, A ^a   Pietruska, M ^a   Paniczko Drezek A ^a   Dolinska E ^a   Zelazowska Rutkowska, B ^a   Zak, J ^a   Pietruski, J ^b   Milewski, R ^a   Wysocka, J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Dental Practice   (Poland)

Author keywords

aggressive periodontitis; chronic periodontitis; metalloproteinases; ozone; ozonotherapy

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; NEUTROPHIL COLLAGENASE; OZONE;

ADULT; AGED; ARTICLE; CHRONIC PERIODONTITIS; FEMALE; GINGIVA BLEEDING; HUMAN; MAJOR CLINICAL STUDY; MALE; OZONE THERAPY; PREVENTIVE DENTISTRY; SALIVA LEVEL; TOOTH PLAQUE;

EID: 78650503860     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.2478/v10039-010-0048-x     Document Type: Article

References (37)

1. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med. 1993;4(2):197-250.
2. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol. 1993 May;64(5 Suppl):474-84.
3. Reynolds JJ, Meikle M. Mechanisms of connective tissue matrix destruction in periodontitis. Periodontol 2000. 1997 Jun;14:144-57.
4. Sorsa T, Tjäderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis. 2004 Nov;10(6):311-8.
5. Chen HY, Cox SW, Eley BM, Mäntylä P, Rönkä H, Sorsa T. Matrix metalloproteinase-8 levels and elastase activities in gingival crevicular fluid from chronic adult periodontitis patients. J Clin Periodontol. 2000 May;27(5):366-9.
6. Cole AA, Chubinskaya S, Schumacher B, Huch K, Cs-Szabo G, Yao J, Mikecz K, Hasty KA, Kuettner K. Chondrocyte matrix metalloproteinase-8. J Biol Chem. 1996 May 3;271(18):11023-6.
7. Kiili M, Cox SW, Chen HY, Wahlgren J, Maisi P, Eley BM, Salo T, Sorsa T. Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: Molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J Clin Periodontol. 2002 Mar;29(3):224-32.
8. Kinney JS, Ramseier CA, Giannobile WV. Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann NY Acad Sci. 2007 Mar;1098:230-51.
9. Ozmeric N. Advances in periodontal disease markers. Clin Chim Acta, 2004; 343: 1-16
10. Ingman T, Sorsa T, Michaelis J, Konttinen YT. Immunohistochemical study of neutrophil- and fibroblast-type collegenase and stromelysin-1 in adult periodontitis. Scand J Dent Res. 1994 Dec;102(6):342-9.
11. Golub LM, Lee HM, Greenwald RA, Ryan ME, Sorsa T, Salo T, Giannobile WV. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res. 1997 Aug;46(8):310-9.
12. Ingman T, Tervahartiala T, Ding Y, Tschesche H, Haerian A, Kinane DF, Konttinen YT, Sorsa T. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol. 1996 Dec;23(12):1127-32.
13. Brauner AW. Periodontology: New Methods. Ozone: Science & Engineering. 1992;14(2):165-76.
14. Menabde GT, Natroshvili ND, Natroshvili TD. [Ozonotherapy for the treatment of periodontitis]. Georgian Med News. 2006 May;(134):43-6. [Article in Russian]
15. Holmes J. Clinical reversal of root caries using ozone, double-blind, randomised, controlled 18-month trial. Gerodontology. 2003 Dec;20(2):106-14.
16. Christodoulides N, Floriano PN, Miller CS, Ebersole JL, Mohanty S, Dharshan P, Griffin M, Lennart A, Ballard KL, King CP Jr, Langub MC, Kryscio RJ, Thomas MV, McDevitt JT. Lab-on-a-chip methods for point-of-care measurements of salivary biomarkers of periodontitis. Ann NY Acad Sci. 2007 Mar;1098:411-28.
17. Miller CS, King CP Jr, Langub MC, Kryscio RJ, Thomas MV. Salivary biomarkers of existing periodontal disease: A cross-sectionary study. J Am Dent Assoc. 2006 Mar;137(3):322-9.
18. Agan, S, Sönmez S, Serdar M. The effects of topical doxycycline usage on gingival crevicular fluid MMP-8 levels of chronic and aggressive periodontitis patients: A pilot study. Int J Dent Hyg. 2006 Aug;4(3):114-21.
19. Kinane DF, Darby IB, Said S, Luoto H, Sorsa T, Tikanoja S, Mäntylä P. Changes in gingival crevicular fluid matrix metalloproteinase-8 levels during periodontal treatment and maintenance. J Periodontal Res. 2003 Aug;38(4):400-4.
20. Pozo P, Valenzuela MA, Melej C, Zaldívar M, Puente J, Martínez B, Gamonal J. Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patients. J Periodontal Res. 2005 Jun;40(3):199-207.
21. Tüter G, Kurtis B, Serdar M, Aykan T, Okyay K, Yücel A, Toyman U, Pinar S, Cemri M, Çengel A, Walker SG, Golub LM. Effect of scaling and root planning and subantimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease. J Clin Periodontol. 2007 Aug;34(8):673-81.
22. Uitto VJ, Suomalainen K, Sorsa T. Salivary collagenase. Origin, characteristics and relationship to periodontal health. J Periodontal Res. 1990 May;25(3):135-42.
23. Bocci V. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res. 2006 May;37(4):425-35.
24. Bocci V. Is it true that ozone is always toxic? The end of a dogma. Toxicol Appl Pharmacol. 2006 Nov 1;216(3):493-504.
25. Bocci V. Ozone as Janus: This controversial gas can be either toxic or medically useful. Mediators Inflamm. 2004 Feb;13(1):3-11.
26. Nichols TC, Fischer TH, Deliargyris EN, Baldwin AS Jr. Role of nuclear factor-kappa B (NF-kappa B) in inflammation, periodontitis and atherogenesis. Ann Periodontol. 2001 Dec;6(1):20-9.
27. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibitor of the NF -kappaB pathway in the treatment of inflammation and cancer. J Clin Invest. 2001 Jan;107(2):135-42.
28. Huth KC, Saugel B, Jakob FM, Cappello C, Quirling M, Paschos E, Ern K, Hickel R, Brand K. Effect of aqueous ozone on the NF-kappaB system. J Dent Res. 2007 Mar;86(5):451-6.
29. Bocci V, Valacchi G, Corradeschi F, Aldinucci C, Silvestri S, Paccagnini E, Gerli R. Studies on the biological effects of ozone: 7. Genetarion of reactive oxygen species (ROS) after exposure of human blood to ozone. J Biol Regul Homeost Agents. 1998 Jul-Sep;12(3):67-75.
30. Bocci V. Ozone as a bioregulator. Pharmacology and toxicology of ozonetherapy today. J Biol Regul Homeost Agents. 1996 Apr-Sep;10(2-3):31-53.
31. Reynolds JJ. Collagenases and tissue inhibitors of metalloproteinases: A functional balance in tissue degradation. Oral Dis. 1996 Mar;2(1):70-6.
32. Reynolds JJ, Hembry RM, Meikle MC. Connective tissue degradation in health and periodontal disease and the roles of matrix metalloproteinases and their natural inhibitors. Adv Dent Res. 1994 Jul;8(2):312-9.
33. Korostoff JM, Wang JF, Sarment DP, Stewart JC, Feldman RS, Billings PC. Analysis of in situ protease activity in chronic adult periodontitis patients: Expression of activated MMP-2 and a 40 kDa serine protease. J Periodontol. 2000 Mar;71(3):353-60.
34. Lynch E. Leczenie prochnicy za pomoca ozonu. Quintessence dla lekarzy stomatologów. 2003; 11:198-200.
35. Bocci V. Ozone: A new medical drug 1st ed. Dortrecht: Springer; 2005, p 162 36.
36. Górnicki A, Gutsze A. In vitro effects of ozone on human erythrocyte membranes: An EPR study. Acta Biochim Pol. 2000;47(4):963-71.
37. Valacchi G, Bocci V. Studies on the biological effects of ozone: 11. Release of factors from human endothelial cells. Mediators Inflamm. 2000; 9(6):271-6.